2020
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
Who has approved Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine, COVISHIELD, in India?
|
|
DARPG
|
|
|
CSIR
|
|
|
ICMR
|
|
|
DCGI
|
Explanation:
Detailed explanation-1: -Serum Institute of India: Covishield (Oxford/ AstraZeneca formulation) – COVID19 Vaccine Tracker.
Detailed explanation-2: -The European Medicines Agency decided that Vaxzevria’s benefits are greater than its risks and it can be authorised for use in the EU.
Detailed explanation-3: -The UK became the first country in the world to approve the Oxford University/AstraZeneca COVID-19 vaccine a year ago today (Thursday 30 December).
Detailed explanation-4: -COVAXIN - India’s First Indigenous Covid-19 Vaccine | Bharat Biotech.
There is 1 question to complete.